Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
spastic paraplegia 41 (autosomal dominant) | 1.000 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
zona pellucida glycoprotein 1 | 0.890 | 1.9E-21 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
zona pellucida glycoprotein 1 | 0.890 | 1.9E-21 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
schlafen family member 14 | 0.931 | 3.5E-09 |
|
disease | 0.700 | None | 1.000 | 1 | 0 | 2015 | 2016 | |||||||||
|
regulator of G protein signaling 9 binding protein | 0.931 | 2.3E-03 |
|
phenotype | 0.700 | limited | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
rabenosyn, RAB effector | 1.000 | 2.3E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
zona pellucida glycoprotein 2 | 0.931 | 6.2E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
zona pellucida glycoprotein 2 | 0.931 | 6.2E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
dystonia 17 | 1.000 | 0.038 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
cilia and flagella associated protein 43 | 0.931 | 0.038 | 1.3E-22 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
septin 14 | 0.805 | 0.077 | 6.9E-06 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2013 | 2013 | ||||||||
|
septin 14 | 0.805 | 0.077 | 6.9E-06 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 2013 | 2013 | ||||||||
|
NUT family member 2A | 0.805 | 0.077 | 5.4E-07 |
|
disease | 0.360 | None | 1.000 | 2 | 0 | 2012 | 2017 | ||||||||
|
spinocerebellar ataxia 30 | 0.931 | 0.077 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
dystonia 21, torsion (autosomal dominant) | 0.931 | 0.077 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
Macular dystrophy, North Carolina type | 1.000 | 0.077 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
odontogenesis associated phosphoprotein | 0.839 | 0.077 | 5.0E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
GTPase activating protein and VPS9 domains 1 | 1.000 | 0.077 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
centrosomal protein 83 | 0.839 | 0.077 | 4.3E-14 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
spastic paraplegia 29 (autosomal dominant) | 0.931 | 0.077 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
RELT TNF receptor | 0.821 | 0.077 | 1.1E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
RAB28, member RAS oncogene family | 0.792 | 0.077 | 2.5E-02 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2013 | 2016 | ||||||||
|
spastic paraplegia 37 (autosomal dominant) | 1.000 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spastic paraplegia 19 (autosomal dominant) | 0.931 | 0.077 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
spastic paraplegia 24 (autosomal recessive) | 0.931 | 0.077 |
|
disease | 0.300 | None | 0 | 0 |